Evidence map›Paper›PMID 38929124›Full record

ArticleAntioxidants (Basel, Switzerland)2024

Neuroinflammation and Lysosomal Abnormalities Characterise the Essential Role for Oxidation Resistance 1 in the Developing and Adult Cerebellum.

Eboni M V Bucknor, Errin Johnson, Stephanie Efthymiou, Javeria R Alvi, Tipu Sultan, Henry Houlden, Reza Maroofian, Ehsan G Karimiani, Mattéa J Finelli, Peter L Oliver

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eboni M V BucknorMammalian Genetics Unit, MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK.
Errin JohnsonThe Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
Stephanie EfthymiouDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1B 5EE, UK.ORCID 0000-0003-4900-9877
Javeria R AlviDepartment of Pediatric Neurology, Children Hospital, University of Child Health Sciences, Lahore 54660, Pakistan.ORCID 0000-0002-3452-1862
Tipu SultanDepartment of Pediatric Neurology, Children Hospital, University of Child Health Sciences, Lahore 54660, Pakistan.
Henry HouldenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1B 5EE, UK.
Reza MaroofianDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1B 5EE, UK.
Ehsan G KarimianiMolecular and Clinical Sciences Institute, St. George's University of London, Cranmer Terrace, London SW18 0RE, UK.
Mattéa J FinelliSchool of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK.ORCID 0000-0002-0152-3642
Peter L OliverMammalian Genetics Unit, MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK.ORCID 0000-0003-3347-2461

Funding

Medical Research Council G0601943Medical Research Council MR/P502005/1Medical Research Council MR/S005021/1Medical Research Council MR/S01165X/1Wellcome TrustWellcome Trust WT093205MAWellcome Trust WT104033AIA
6 · The paper itself

Abstract

Loss-of-function mutations in the TLDc family of proteins cause a range of severe childhood-onset neurological disorders with common clinical features that include cerebellar neurodegeneration, ataxia and epilepsy. Of these proteins, oxidation resistance 1 (OXR1) has been implicated in multiple cellular pathways related to antioxidant function, transcriptional regulation and cellular survival; yet how this relates to the specific neuropathological features in disease remains unclear. Here, we investigate a range of loss-of-function mouse model systems and reveal that constitutive deletion of

Indexed as

ataxiacerebellumlysosomeneuroinflammationoxidative stress

Identifiers

PMID38929124
PMCPMC11201099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.